Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06961929

IEEM-Heat and Heart Failure

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
University of Texas Southwestern Medical Center · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Accepted

Summary

We will test the hypothesis that increasing skin wetness, and thus evaporative cooling, will attenuate the increase in core body temperature and accompanying cardiac stress during heat wave conditions in individuals with congestive heart failure. Secondly, we propose that wearing a water-saturated T-shirt will also be beneficial to attenuate the increase in core body temperature and accompanying cardiac stress during heat wave conditions in individuals with congestive heart failure. To accomplish these objectives, individuals with congestive heart failure and otherwise healthy control individuals will be exposed to the simulated heat wave condition (hot and dry) with the following cooling modalities: A) control trial (no limb immersion or skin wetting), B) skin wetting only trial, and C) water-saturated T-shirt trial in a randomized crossover fashion. Thermoregulatory and cardiovascular responses will be evaluated throughout these simulated heat wave exposures. Primary outcomes variables will be skin and core temperatures, while secondary variables will include measures of cardiovascular stress, myocardial perfusion, heart rate, and echo-based measures of cardiac function.

Conditions

Interventions

TypeNameDescription
OTHERControl TrialAll participants will be exposed to a period of hyperthermia (hot and dry). In this condition, participants will not be given an experimental cooling modality.
OTHERWater-saturated T-shirt trialAll participants will be exposed to a period of hyperthermia (hot and dry). In this condition, participants will also wear a T-shirt that has been saturated with water.
OTHERSkin-Wetting TrialAll participants will be exposed to a period of hyperthermia (hot and dry). In this condition, participants will also be sprayed with water periodically.

Timeline

Start date
2025-10-01
Primary completion
2030-07-01
Completion
2030-07-01
First posted
2025-05-08
Last updated
2026-03-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06961929. Inclusion in this directory is not an endorsement.